1. Home
  2. APYX vs CCCC Comparison

APYX vs CCCC Comparison

Compare APYX & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.27

Market Cap

156.7M

Sector

Health Care

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.11

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
CCCC
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.7M
185.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
APYX
CCCC
Price
$3.27
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$7.00
$12.20
AVG Volume (30 Days)
90.9K
2.0M
Earning Date
04-03-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
$9.36
N/A
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$0.83
$1.09
52 Week High
$4.50
$3.64

Technical Indicators

Market Signals
Indicator
APYX
CCCC
Relative Strength Index (RSI) 37.92 72.10
Support Level $3.30 $1.96
Resistance Level $4.40 N/A
Average True Range (ATR) 0.21 0.27
MACD -0.06 0.12
Stochastic Oscillator 19.39 92.71

Price Performance

Historical Comparison
APYX
CCCC

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: